More Globe Newswire

View Older Stories View Newer Stories

Sep 29, 2026 08:05AM Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis
Sep 29, 2026 08:05AM Tessera Sets 2027 Revenue Target of $14–16 Million and Outlines Path to Approximately $30 Million by 2029
Sep 29, 2026 08:05AM Zyxel Partners with Streakwave to Expand Access to Outdoor Wireless Solutions
Sep 29, 2026 08:04AM Alm. Brand A/S – Weekly report on share buybacks
Sep 29, 2026 08:04AM Middlefield Launches Alternative Global Fixed Income Fund
Sep 29, 2026 08:03AM Silexion Therapeutics Announces Exercise of Warrants
Sep 29, 2026 08:03AM Coinbax Extends Payment Controls to FedNow and RTP Payments, Opens Design Partner Program for Banks and Credit Unions
Sep 29, 2026 08:03AM New Report Finds Average Brand is Invisible in 84% of Target Responses in AI Search
Sep 29, 2026 08:02AM Delinea Report Finds 87% of Organizations Saw an AI Tool Access Sensitive Data Beyond Its Scope in the Past Year
Sep 29, 2026 08:00AM Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda
Sep 29, 2026 08:00AM ZeroEyes Partners With Samson Security Fire & Facilities to Bring Human-Verified Threat Detection to the United Kingdom
Sep 29, 2026 08:00AM MAX Power’s Lawson 5 Approaches Key Salt Horizon in 30-km Step-Out Testing Basin Scale Natural Hydrogen Potential
Sep 29, 2026 08:00AM Precision Optics to Participate in the Lytham Partners Fall 2026 Investor Conference
Sep 29, 2026 08:00AM Asure Launches AsureCentral to Its Reseller Network, Extending Its Unified Platform to 85,000 More Employers
Sep 29, 2026 08:00AM Claris Bio Announces Oral Presentations at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting and Eyecelerator @ AAO
Sep 29, 2026 08:00AM Airia Makes Real-Time Policy Enforcement for Claude Generally Available
Sep 29, 2026 08:00AM Apyx Medical Announces New Clinical Study Demonstrating Renuvion®’s Impact on Skin Quality
Sep 29, 2026 08:01AM Seerist and Janes Bring Real-Time Global Risk Signals and Validated Military Intelligence into One Workflow
Sep 29, 2026 08:00AM ZenaTech Reports 425% First Half and 316% Second-Quarter Year-Over-Year Revenue Growth as Drone as a Service Segment Continues to Scale
Sep 29, 2026 08:00AM Commerce Introduces Data Enrichment for BigCommerce and Feedonomics to Power Agentic Commerce
Sep 29, 2026 08:00AM Savaria’s Executive Chairman Completes Secondary Sale of Securities
Sep 29, 2026 08:00AM WeShop to Launch in the U.S. November 16: Community-Owned Shopping App Puts Consumers at the Center of a New Model Built Around Rewards, Participation and Ownership
Sep 29, 2026 08:00AM ABM and Arizona Cardinals Highlight Partnership at State Farm Stadium
Sep 29, 2026 08:00AM DiFusion to Define Therapeutic Biomaterials Category at NASS 2026
Sep 29, 2026 08:00AM Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development
Sep 29, 2026 08:00AM Komprise Breaks the AI Context Barrier and Reduces MCP Bloat with New Universal File MCP Solution
Sep 29, 2026 08:00AM New research reveals a great divide in beauty, health & wellness, with executives and consumers at odds
Sep 29, 2026 08:00AM BIO-Europe 2026 to Convene Global Biopharma Decision-Makers in Cologne
Sep 29, 2026 08:00AM EMS Innovations’ The RISER Named “Caregiver Support Product of the Year” In 2026 Senior Innovation Awards
Sep 29, 2026 08:00AM Noah Medical’s Galaxy System Enters Commercial Use in Asia with First Procedure Completed in Hong Kong
Sep 29, 2026 08:00AM Microchip Expands Single Pair Ethernet Portfolio with New 10BASE‑T1S Devices Enabling Scalable Edge Connectivity
Sep 29, 2026 08:00AM American Fusion Inc. (OTCQB: AMFN) Outlines Texatron™ Plasma Compression and Confinement Approach in New Technical Analysis
Sep 29, 2026 08:00AM Trane Technologies Launches LiquidStack CDU 2.X for Faster, More Flexible AI Cooling Deployments
Sep 29, 2026 08:00AM Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer
Sep 29, 2026 08:00AM Maris-Tech Completes Development of Diamond Ultra V2, Its Next-Generation Video and AI Platform
Sep 29, 2026 08:00AM AXIL Brands to Announce First Quarter Fiscal 2027 Financial Results on October 6, 2026
Sep 29, 2026 08:00AM Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting
Sep 29, 2026 08:00AM Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron
Sep 29, 2026 08:00AM SaverOne Awarded U.S. Patent for Automated Sensor Fusion Calibration and Maintenance: Strengthening its IP Protection as Fleet Deployments Scale
Sep 29, 2026 08:00AM HUHUTECH Expects Two Japan Projects with Estimated Aggregate Value of Approximately $12 Million to Advance Toward Contracting in Q4 2026
Sep 29, 2026 08:00AM Diginex (NASDAQ: DGNX) Launches Enhanced End-to-End Supply Chain Platform Targeting $7+ Billion Market by 2029, Growing at 29% CAGR
Sep 29, 2026 08:00AM Starling Launches New CTV Platform Built for the Next Era of Television Advertising
Sep 29, 2026 08:00AM IMUNON Converts $1.2 Million of Debt-to-Equity
Sep 29, 2026 08:00AM EagleNXT Participates in Michigan NADWC DDIL Testing Environment Supporting Army Permissive Range Initiative
Sep 29, 2026 08:00AM Leonardo DRS Schedules Third Quarter 2026 Earnings Conference Call for October 29, 2026
Sep 29, 2026 08:00AM TMC Announces Appointment of Liam Mallon, Former President of ExxonMobil Upstream, to its Board of Directors
Sep 29, 2026 08:00AM Phase III Trial Demonstrates Veracyte’s Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
Sep 29, 2026 08:00AM Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
Sep 29, 2026 08:00AM Fetch Pet Insurance Launches Fetch Online Vet Powered by Vetster, With No Out-of-Pocket Costs or Claims to File
Sep 29, 2026 08:00AM NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease
View Newer Stories View Older Stories